20/20 Biolabs

AIDX · NASDAQ

$0.265+$0.0047 (+1.81%)TodayMarket closed · Oct 20, 7:40 PM ET

Prev close $0.2603

About AIDX

20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The firm offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.

Employees: 4
Headquarters: Rockville, Maryland
Listed: Sep 8, 2021
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: 2020gene.com

Leadership

20/20 Biolabs executives
Name	Title
Jonathan Cohen	—
Jiming Zhou	—
Michael Lebowitz	—
Michael Ross	—

Similar companies

Companies in the same industry as 20/20 Biolabs

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.